M J Lage

Summary

Publications

  1. doi request reprint Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate
    Maureen J Lage
    HealthMetrics Outcomes Research, 120 Anchorage Circle, Groton, CT 06340, USA
    Adv Ther 26:762-75. 2009
  2. ncbi request reprint Effect of immunomodulatory therapy and other factors on employment loss time in multiple sclerosis
    M J Lage
    HealthMetrics Outcomes Research, Groton, CT, USA
    Work 27:143-51. 2006
  3. doi request reprint Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations
    Dawn I Velligan
    Dr Velligan is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio Dr Carroll is with Xcenda, Charlotte, North Carolina, and completed work on this project while employed at Teva Pharmaceuticals, Kansas City, Missouri Dr Lage is with HealthMetrics Outcomes Research, Bonita Springs, Florida Ms Fairman is with Kathleen Fairman, Ltd, Phoenix, Arizona Send correspondence to Dr Lage e mail
    Psychiatr Serv 66:127-33. 2015
  4. pmc Updated cost-of-care estimates for commercially insured patients with multiple sclerosis: retrospective observational analysis of medical and pharmacy claims data
    Cathryn A Carroll
    Kathleen Fairman LTD, 11208 North 23rd Place, Phoenix, AZ, USA
    BMC Health Serv Res 14:286. 2014
  5. pmc The impact of comorbid depression on adherence to therapy for multiple sclerosis
    M Tarrants
    Medical Affairs, Teva Pharmaceuticals, 901 East 104th Street, Suite 900, Kansas City, MO 64131, USA
    Mult Scler Int 2011:271321. 2011
  6. doi request reprint Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy
    Maureen J Lage
    HealthMetrics Outcomes Research LLC, 120 Anchorage Circle, Groton, Connecticut 06340, USA
    Adv Ther 26:217-29. 2009
  7. ncbi request reprint Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer
    M J Lage
    HealthMetrics Outcomes Research, LLC, Groton, Connecticut, USA
    Urology 70:1104-8. 2007
  8. pmc The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective study
    Maureen J Lage
    Health Metrics Outcomes Research, Groton, CT, USA
    Ann Gen Psychiatry 8:7. 2009
  9. doi request reprint Healthcare costs in postmenopausal women with hormone-positive metastatic breast cancer
    Maureen J Lage
    HealthMetrics Outcomes Research, Groton, CT 06340, USA
    J Med Econ 13:691-7. 2010
  10. ncbi request reprint The cost of treating skeletal-related events in patients with prostate cancer
    Maureen J Lage
    HealthMetrics Outcomes Research, LLC, 120 Anchorage Cir, Groton CT 06340, USA
    Am J Manag Care 14:317-22. 2008

Collaborators

  • David J Harrison
  • Rohit Borker
  • Gene L Colice
  • Zhongyun Zhao
  • H G Birnbaum
  • M A Oleen-Burkey
  • Dawn I Velligan
  • Cathryn A Carroll
  • M Tarrants
  • Kristina Secnik Boyc
  • Martin D Marciniak
  • Baojin Zhu
  • Kristina Secnik
  • Lee Bowman
  • Ronald P Landbloom
  • Eduardo Dunayevich
  • Martin Marciniak
  • Jacqueline Pesa
  • Karen L Rascati
  • Kathleen Fairman
  • Cathy Carroll
  • Kathleen A Fairman
  • J Castelli-Haley
  • Nicole Yurgin
  • Louise R Levine
  • Mauricio Tohen
  • James M Russell
  • Andrine Swensen
  • Lizheng Shi
  • Robert W Baker
  • Sandra L Tunis
  • Beth L Barber
  • M Lynn Crismon
  • Michael T Johnsrud

Detail Information

Publications19

  1. doi request reprint Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate
    Maureen J Lage
    HealthMetrics Outcomes Research, 120 Anchorage Circle, Groton, CT 06340, USA
    Adv Ther 26:762-75. 2009
    ..Examine outcomes and costs of patients with persistent asthma who initiated treatment with beclomethasone dipropionate hydrofluoroalkane (BDP-HFA) or fluticasone propionate (FP)...
  2. ncbi request reprint Effect of immunomodulatory therapy and other factors on employment loss time in multiple sclerosis
    M J Lage
    HealthMetrics Outcomes Research, Groton, CT, USA
    Work 27:143-51. 2006
    ..24 fewer days, P<0.03), worker's compensation (29.50 fewer days, P<0.04) or any reason (53.70 fewer days, P< 0.003)...
  3. doi request reprint Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations
    Dawn I Velligan
    Dr Velligan is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio Dr Carroll is with Xcenda, Charlotte, North Carolina, and completed work on this project while employed at Teva Pharmaceuticals, Kansas City, Missouri Dr Lage is with HealthMetrics Outcomes Research, Bonita Springs, Florida Ms Fairman is with Kathleen Fairman, Ltd, Phoenix, Arizona Send correspondence to Dr Lage e mail
    Psychiatr Serv 66:127-33. 2015
    ..This analysis compared utilization and cost outcomes for cohorts of Medicaid beneficiaries treated with clozapine monotherapy and with antipsychotic polypharmacy...
  4. pmc Updated cost-of-care estimates for commercially insured patients with multiple sclerosis: retrospective observational analysis of medical and pharmacy claims data
    Cathryn A Carroll
    Kathleen Fairman LTD, 11208 North 23rd Place, Phoenix, AZ, USA
    BMC Health Serv Res 14:286. 2014
    ..To support contemporary pharmacoeconomic analyses, the present study was conducted to provide updated information about MS-related costs and cost drivers including DMDs...
  5. pmc The impact of comorbid depression on adherence to therapy for multiple sclerosis
    M Tarrants
    Medical Affairs, Teva Pharmaceuticals, 901 East 104th Street, Suite 900, Kansas City, MO 64131, USA
    Mult Scler Int 2011:271321. 2011
    ..Although treatment with antidepressant therapy generally did not improve the likelihood of adherence, treatment with antidepressants for at least 6 months was associated with better adherence to DMT...
  6. doi request reprint Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy
    Maureen J Lage
    HealthMetrics Outcomes Research LLC, 120 Anchorage Circle, Groton, Connecticut 06340, USA
    Adv Ther 26:217-29. 2009
    ..The purpose of this analysis was to compare costs among patients with type 2 diabetes (T2D) treated with either of these agents...
  7. ncbi request reprint Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer
    M J Lage
    HealthMetrics Outcomes Research, LLC, Groton, Connecticut, USA
    Urology 70:1104-8. 2007
    ..Given that metabolic syndrome is related to diabetes, this research examined whether use of ADT was associated with an increase in the incidence of diabetes...
  8. pmc The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective study
    Maureen J Lage
    Health Metrics Outcomes Research, Groton, CT, USA
    Ann Gen Psychiatry 8:7. 2009
    ..This observational study examined the association between adherence to antipsychotics and risk of hospitalizations and emergency room (ER) visits among patients with bipolar disorder...
  9. doi request reprint Healthcare costs in postmenopausal women with hormone-positive metastatic breast cancer
    Maureen J Lage
    HealthMetrics Outcomes Research, Groton, CT 06340, USA
    J Med Econ 13:691-7. 2010
    ..This study examines costs for postmenopausal women with hormone receptor positive (HR+) metastatic breast cancer (mBC)...
  10. ncbi request reprint The cost of treating skeletal-related events in patients with prostate cancer
    Maureen J Lage
    HealthMetrics Outcomes Research, LLC, 120 Anchorage Cir, Groton CT 06340, USA
    Am J Manag Care 14:317-22. 2008
    ..To examine the economic burden of skeletal-related events (SREs) and to assess the frequency of different types of SREs in this population...
  11. doi request reprint The relationship between alternative medication possession ratio thresholds and outcomes: evidence from the use of glatiramer acetate
    M A Oleen-Burkey
    Health Economics and Outcomes Research, Teva Pharmaceuticals, Kansas City, MO 64131, USA
    J Med Econ 14:739-47. 2011
    ..To examine how changes in the medication possession ratio (MPR) affect the probability of multiple sclerosis (MS) relapses and total and MS-related charges among patients treated with glatiramer acetate (GA)...
  12. doi request reprint Costs and resource use of mild persistent asthma patients initiated on controller therapy
    Gene L Colice
    The George Washington University School of Medicine and Washington Hospital Center, Washington, DC, USA
    J Asthma 45:293-9. 2008
    ..The treatment of mild persistent asthma is controversial...
  13. ncbi request reprint Trends in the prescription of antidiabetic medications in France: evidence from primary care physicians
    Kristina Secnik Boyc
    Eli Lilly and Company, Indianapolis, Indiana, USA
    Adv Ther 24:803-13. 2007
    ..05). In France, antidiabetic medication prescribing patterns changed from 2001 to 2003. In general, the trend has been away from sulfonylurea monotherapy and toward metformin monotherapy, insulin monotherapy, or combination therapy...
  14. ncbi request reprint The cost of treating anxiety: the medical and demographic correlates that impact total medical costs
    Martin D Marciniak
    Lilly Research Laboratories, Indianapolis, IN, USA
    Depress Anxiety 21:178-84. 2005
    ....
  15. ncbi request reprint Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial
    Baojin Zhu
    Lilly Research Laboratories, Indianapolis, IN, USA
    Curr Med Res Opin 21:555-64. 2005
    ....
  16. ncbi request reprint Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder
    Kristina Secnik
    Lilly Research Laboratories, Indianapolis, Indiana, USA
    Pharmacoeconomics 23:93-102. 2005
    ..The purpose of this retrospective study was to examine the prevalence of comorbidities, resource use, direct medical costs, and the costs associated with missed work for adults diagnosed with attention-deficit hyperactivity disorder (ADHD)...
  17. ncbi request reprint The medical costs of migraine and comorbid anxiety and depression
    Jacqueline Pesa
    Health Economics and Outcomes Research, AstraZeneca, Willmington, DE, USA
    Headache 44:562-70. 2004
    ..To examine the direct medical costs associated with migraine, when diagnosed alone and in conjunction with anxiety and/or depression in adults and children...
  18. ncbi request reprint Medical and productivity costs of anxiety disorders: case control study
    Martin Marciniak
    Lilly Research Laboratories, Indianapolis, Indiana, USA
    Depress Anxiety 19:112-20. 2004
    ..Results indicate that anxiety disorders are associated with significant medical and productivity costs...
  19. ncbi request reprint Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients
    Karen L Rascati
    College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA
    Pharmacoeconomics 21:683-97. 2003
    ....